SIRT1 and COVID-19: Melatonin stimulates the SIRT1 signaling pathway (Shah et al., 2017) and has been suggested as a potential COVID-19 treatment (Zhang R. et al., 2020) and a clinical trial assessing its efficacy as preventive drug is underway218.